Skip to main content

Table 1 Baseline characteristics of the 62 patients

From: RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy

Characteristic

n(%)

Gender

 

   Male

40 (64.5)

   Female

22 (35.5)

Age

 

   ≤ 65 years

50 (80.6)

   >65 years

12 (19.4)

WHO PS

 

   0

11 (17.7)

   1

51 (82.3)

Histology

 

   Squamous cell carcimoma

11 (17.7)

   Adenocarcinoma

46 (74.2)

   Large cell carcinoma

3 (4.8)

   Other NSCLC

2 (3.3)

Stage

 

   IIIA

2 (3.3)

   IIIB

10 (16.1)

   IV

50 (80.6)

Weight loss ≥5%

 

   Yes

13 (21.0)

   No

47 (75.8)

Unknown

2 (3.2)